Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does serum TSH level have thyroid hormone independent effects on bone turnover?

Abstract

Hyperthyroidism-associated bone loss has been attributed to excess of thyroid hormones. Animal studies, however, suggest that TSH deficiency might affect bone turnover independently of thyroid hormones. Here, I discuss the study by Heemstra and colleagues, who assessed the relationship between serum TSH level and markers of bone turnover in patients with thyroid cancer receiving supraphysiological doses of levothyroxine. The effect of thyroid hormones could not be distinguished from that of TSH as the intact hypothalamic–pituitary–thyroid axis maintained the typical inverse relationship between thyroid hormones and TSH. The study included 27 men and 76 premenopausal women, although previous data indicate that suppressive doses of levothyroxine have no effect on BMD in such patients. Accordingly, Heemstra et al. did not identify a relationship between TSH level and BMD. Although mechanisms of thyrotoxicosis-related bone loss remain controversial, postmenopausal women with thyroid cancer who require long-term TSH suppression should be monitored carefully for osteoporosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Murphy E and Williams GR (2004) The thyroid and the skeleton. Clin Endocrinol 61: 285–298

    Article  CAS  Google Scholar 

  2. Bassett JHD and Williams GR (2008) Critical role of the hypothalamic-pituitary-thyroid axis in bone. Bone 43: 418–426

    Article  CAS  PubMed  Google Scholar 

  3. Heemstra KA et al. (2008) Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma. Eur J Endocrinol 159: 69–76

    Article  CAS  PubMed  Google Scholar 

  4. Biondi B et al. (2005) Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 1: 32–40

    Article  CAS  PubMed  Google Scholar 

  5. van der Deure WM et al. (2008) Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin Endocrinol 68: 175–181

    CAS  Google Scholar 

  6. Mazziotti G et al. (2005) Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res 20: 480–486

    Article  CAS  PubMed  Google Scholar 

  7. Giusti M et al. (2007) Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma. Hormones 6: 304–313

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, G. Does serum TSH level have thyroid hormone independent effects on bone turnover?. Nat Rev Endocrinol 5, 10–11 (2009). https://doi.org/10.1038/ncpendmet1004

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet1004

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing